Showing results (341-350 of 401) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 27, 2018
Solid organ transplantation after hematopoietic stem cell transplantation in childhood: A multicentric retrospective surveyMaura Faraci, Alice Bertaina, Arnaud Dalissier, et al.
Blood Cancer Discovery|January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic LeukemiaMichael A Pulsipher, Xia Han, Shannon L Maude, et al.
Blood|May 23, 2022
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Haiying Qin, Angela Su, et al.
British Journal of Haematology|July 21, 2018
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trialMichaela Kuhlen, Peter Bader, Martin Sauer, et al.
Blood Advances|January 20, 2026
Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent yearsFelicia Andresen, Ayami Yoshimi, Peter Bader, et al.
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Blood|September 9, 2004
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trialFranco Locatelli, Peter Nöllke, Marco Zecca, et al.
Blood Advances|March 4, 2026
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM StudyKhalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup, et al.
Pageof 41